Marja Tuuli Nevalainen,Vincent C. O. Njar,Zhiyong Liao,Allen B. Reitz,Mark E. McDonnell
申请号：
US14421608
公开号：
US20150209379A1
申请日:
2013.05.10
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Prostate cancer and hematological neoplasms are treated by administration of (i) a compound of Formula I: wherein: R1 is —OH or —O—P(O)(OH)2 and R2 is (II) or (III) (ii) N6-benzyladenosine, (iii) N-(phenylmethyl)-7-β-D-ribofuranosyl-7H-pyrrolo [2,3 -d]pyrimidin-4-amine, (iv) N-(phenylmethyl)-7β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 5′-monophosphate or a pharmaceutically acceptable salt thereof.
